The Independent Voice of
European Private Equity

Advanced Search

Deal in Focus: Eurazeo exits €1bn ophthalmology platform

Shivani Khandekar 9 January 2024

Sunglasses_shutterstock_1932407525_1000x640.jpg

Eurazeo has sold €1bn-valued Dutch Ophthalmic Research Center (DORC) to Carl Zeiss Meditec, a German ophthalmology and microsurgery business.

Related Articles

Riverside-backed Dastex expands Nordic presence with new acquisition

01/05/24

Lincoln appoints valuations and opinions MD

01/05/24

Locate Bio attracts £9.2m in latest fundraise for LDGraft Clinical Study

01/05/24

Ventech reaps 36x return from exit of digital music company Believe

01/05/24

Polaris takes majority stake in Swedish engineer Vinnergi

01/05/24

Former Monzo leader launches angel fintech fund

01/05/24